Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 23, 2011Clinical Pharmacology & TherapeuticsOpen Access

The Use of Induced Pluripotent Stem Cells in Drug Development

View Full Paper
Ask AI
Bookmark
Share

Authors

HIHaruhisa InoueKyoto University
Shinya Yamanaka
Shinya YamanakaHiroshima University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Inoue et al. (2011) studied this question.

synapsesocial.com/papers/6a85bfb257a6378aebd0c515https://doi.org/10.1038/clpt.2011.38
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Early TCR Expression and Aberrant T Cell Development in Mice with Endogenous Prerearranged T Cell Receptor Genes2007 · 67 citations
  2. 2Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines2007 · 125 citations
  3. 3Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases2010 · 155 citations
  4. 4Direct reprogramming 1012010 · 20 citations